Join
Live feed
·
INSIDERFilingvia Quantisnow
La Jolla Pharmaceutical Company logo

SEC Form 4: Hearne Michael S was granted 1,675 shares, increasing direct ownership by 25% to 8,258 units

ByQuantisnow·Wall Street's wire, on your screen.
LJPC· La Jolla Pharmaceutical Company
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LJPC (La Jolla Pharmaceutical Company) and more on Quantisnow.